Deep Medicine Acquisition Corp. Rights
DMAQR
DMAQR was delisted on the 31st of January, 2024.
24 hedge funds and large institutions have $1.85M invested in Deep Medicine Acquisition Corp. Rights in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 2 closing their positions.
8% less funds holding
Funds holding: 26 → 24 (-2)
23% less capital invested
Capital invested by funds: $2.4M → $1.85M (-$547K)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOA
Sea Otter Advisors
Miami,
Florida
|
+$46.3K |
| 2 |
CS
Clear Street
New York
|
+$1.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
-$73.4K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$46.3K |
| 3 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$46.3K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$45.1K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
-$43.4K |
DMAQR Hedge Fund Activity: Q4 2023 in Review
24 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q4 2023, worth a combined $1.85M — down 23% from $2.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of DMAQR and 0 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 2 added.
The largest buyer was Sea Otter Advisors, adding an estimated $46.3K. The largest seller was Highbridge Capital Management, cutting an estimated $73.4K.
- 24 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q4 2023, down from 26 in Q3 2023.
- Funds reported $1.85M of Deep Medicine Acquisition Corp. Rights stock for Q4 2023, down 23% quarter-over-quarter.
- 0 funds opened new Deep Medicine Acquisition Corp. Rights positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest Deep Medicine Acquisition Corp. Rights buyer in Q4 2023 was Sea Otter Advisors, an estimated $46.3K added.
- The largest Deep Medicine Acquisition Corp. Rights seller in Q4 2023 was Highbridge Capital Management, an estimated $73.4K sold.
Based on aggregated 13F filings for Q4 2023.